Global  

Celebrating 10 Years of Trusted News Discovery
One News Page
> > >

F1 legend Michael Schumacher admitted in Paris hospital for cell therapy surgery, claims report

WorldNews Tuesday, 10 September 2019
F1 legend Michael Schumacher admitted in Paris hospital for cell therapy surgery, claims reportParis: The stricken seven-time Formula One world champion Michael Schumacher is in Paris' Georges-Pompidou hospital for cell therapy surgery, according to French daily Le Parisien. The Paris hospitals department, contacted by AFP, refused to confirm or deny the news citing medical privacy laws. But according to Le Parisien, the 50-year-old...
0
shares
ShareTweetSavePostSend
 
Credit: Reuters - Sports - Published < > Embed
News video: Michael Schumacher admitted to Paris hospital for 'secret treatment' - Le Parisien

Michael Schumacher admitted to Paris hospital for 'secret treatment' - Le Parisien 00:57

The former world champion is receiving treatment based on stem-cell transfusions, according to newspaper report.

Recent related videos from verified sources

26-year-old man with month-long erection after taking Viagra now unable to get it up [Video]26-year-old man with month-long erection after taking Viagra now unable to get it up

A 26-year-old man who had a month-long erection after taking Viagra has now been left unable to get it up - AT ALL.Nat Thind ended up on the operating table with surgeons taking a scalpel to his penis..

Credit: SWNS STUDIO     Duration: 02:31Published

Kylie Jenner Is Hospitalized [Video]Kylie Jenner Is Hospitalized

Kylie Jenner Is Hospitalized. The 22-year-old billionaire was admitted to an undisclosed hospital with flu-like symptoms. . As a result, Jenner won't be able to attend Paris Fashion Week, where her new..

Credit: Wibbitz Studio     Duration: 01:05Published


Recent related news from verified sources

Motorsport: Michael Schumacher's daughter makes heartwarming tribute to F1 legend

Motorsport: Michael Schumacher's daughter makes heartwarming tribute to F1 legend
Ferrari still runs thick through the veins of the Schumacher family.F1 legend Michael, whose condition has been shrouded in secrecy ever since suffering severe...
New Zealand Herald

Celyad Highlights Safety and Clinical Activity of CYAD-101, a First-In-Class, Non-Gene Edited Allogeneic CAR-T Therapy for mCRC, from SITC 34th Annual Meeting

Celyad Highlights Safety and Clinical Activity of CYAD-101, a First-In-Class, Non-Gene Edited Allogeneic CAR-T Therapy for mCRC, from SITC 34th Annual Meeting
MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Regulatory News: Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company...
Business Wire

You Might Like


Tweets about this

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.